99 results
Page 2 of 5
PRE 14A
xtjwoc36
14 Apr 23
Preliminary proxy
5:00pm
8-K
tf04nc1tdqg mag
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
EX-99.1
qn9860fh
16 May 22
Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development
4:09pm
8-K
EX-99.1
7hknuy3bkd8
12 May 22
Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights
4:09pm
8-K
EX-1.1
dtpry7c1ygzx l3pac
28 Apr 22
Other Events
4:20pm
424B5
dro0vmswnf53sjvi6
26 Apr 22
Prospectus supplement for primary offering
4:02pm
424B5
zetv4jcv6w27mawrbq
25 Apr 22
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
64wdk69q3 vlt
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
DEFA14A
xof7ajhxni9 sc6fe5
21 Apr 22
Additional proxy soliciting materials
4:05pm
8-K
y2q69a2e7
29 Mar 22
Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors
8:11am
S-8
r0vtn7u yzo13y8
17 Mar 22
Registration of securities for employees
4:49pm
S-8
EX-23.1
i8ubm3u xm2e2z4kh1ay
17 Mar 22
Registration of securities for employees
4:49pm